Abstract
Current approaches to quantify and diagnose sleep disorders and circadian rhythm disruption are imprecise, laborious, and often do not relate well to key clinical and health outcomes. Newer emerging approaches that aim to overcome the practical and technical constraints of current sleep metrics have considerable potential to better explain sleep disorder pathophysiology and thus to more precisely align diagnostic, treatment and management approaches to underlying pathology. These include more fine-grained and continuous EEG signal feature detection and novel oxygenation metrics to better encapsulate hypoxia duration, frequency, and magnitude readily possible via more advanced data acquisition and scoring algorithm approaches. Recent technological advances may also soon facilitate simple assessment of circadian rhythm physiology at home to enable sleep disorder diagnostics even for “non-circadian rhythm” sleep disorders, such as chronic insomnia and sleep apnea, which in many cases also include a circadian disruption component. Bringing these novel approaches into the clinic and the home settings should be a priority for the field. Modern sleep tracking technology can also further facilitate the transition of sleep diagnostics from the laboratory to the home, where environmental factors such as noise and light could usefully inform clinical decision-making. The “endpoint” of these new and emerging assessments will be better targeted therapies that directly address underlying sleep disorder pathophysiology via an individualized, precision medicine approach. This review outlines the current state-of-the-art in sleep and circadian monitoring and diagnostics and covers several new and emerging approaches to better define sleep disruption and its consequences.
Introduction
Sleep, along with diet and exercise, is essential for optimal health and wellbeing. However, globally, nearly 2 billion people are estimated to have one or both of the two most common clinical sleep disorders–sleep apnea () and insomnia (Roth et al., 2011). Most people with sleep disorders remain undiagnosed and untreated, and thus vulnerable to the major adverse health and safety consequences associated with untreated sleep disorders.
Current sleep apnea diagnostic approaches rely on traditional labor-intensive overnight sleep tests and subjective manual scoring approaches developed around the constraints of paper-based methods from the 1960’s. This approach, in combination with the advent of continuous positive airway pressure (CPAP) to reverse airway collapse during sleep (Sullivan et al., 1981), led to rapid advances in the modern field of sleep medicine. Although efficacious irrespective of underlying mechanisms, sub-optimal patient acceptance and use of CPAP remain problematic and warrant personalized treatments that better target underlying causal mechanisms. However, traditional sleep assessment methods fail to identify the specific underlying causes and consequences of sleep disorders for individual patients. For example, relationships between perceived sleep quality and/or sleepiness and objective sleep measures derived from traditional gold-standard polysomnography are either absent, weak, or inconsistent (; Sforza et al., 2015; ). In the case of insomnia, diagnosis relies on clinical evaluation since traditional objective sleep measures do not relate to disorder incidence, severity, or recovery. While the gold standard treatment, cognitive behavioral therapy for insomnia (CBT-I) is efficacious for many, it is ineffective or only partially effective for some patients (Trauer et al., 2015). This is potentially because, like CPAP for sleep apnea, CBT-I is a one-size-fits-all treatment regardless of the underlying causal mechanisms (Harvey and Tang, 2003). As such, usual care for sleep disorders typically relies on a trial-and-error treatment approach which often fails to identify the underlying causes of sleep disruption or adequately address patient symptoms and health consequences for which individuals seek treatment. Accordingly, this review focuses on highlighting new and emerging approaches to better define sleep and circadian disruption that underpins sleep disorders based on their underlying pathophysiology and accompanying health impacts.
Current State of the Art for Sleep Recording
Current gold-standard methodology to quantify sleep relies on overnight polysomnographic (PSG) recordings. This includes collection of a wealth of neurophysiological data from electroencephalography (EEG), electrooculography (EOG), electromyography (EMG), electrocardiography (ECG), body position and movement, and respiratory-related signals including airflow, chest and abdominal motion, and oximetry. These signals are then manually reviewed and analyzed to classify wake, light through to deep non-rapid eye movement (NREM) (N1, N2, and N3), and rapid eye movement (REM) sleep in 30-s epochs. Transient cortical arousals (3–15 s) and longer awakening (>15 s) events are also manually scored on the basis of internationally standardized American Academy of Sleep Medicine (AASM) EEG criteria ().
Traditional polysomnography scoring evolved from observations of behavioral responsiveness changes coincident with changes in EEG patterns of activity at a time when chart recorders necessitated manual scoring, quite literally page-by-30-s-page (Rechtschaffen, 1968). This pattern-matching “bottom-up” approach to sleep medicine was based on the practical constraints with the technology available at the time, rather than being driven by an understanding of underlying sleep neurobiology. Although computerized systems have replaced paper-based recordings, and despite exponential advances in modern computing, sleep medicine remains predominantly based on these manual scoring methods from the 1960s. Manual scoring is labor intensive, and therefore costly, and captures only gross visually discernible EEG features with much poorer time and frequency resolution than is available within the data (Figure 1). Thus, EEG scoring into discrete 30-s epochs ignores that wake and sleep are continuous and dynamic states, whereby physiological features within epochs classified as wake can be present during sleep, and vice versa (Prerau et al., 2014; Scott et al., 2020). Manual scoring also has large intra- and inter-scorer variability, which remains problematic in sleep medicine despite AASM scoring criteria updates that attempt to reduce scoring variability (Ruehland et al., 2009; Magalang et al., 2013).
FIGURE 1
A New Way of Thinking: Top-Down Sleep Signal Features Based on Underlying Neurobiology Rather Than Bottom-Up Measurement Convenience Guided Approaches
Automated sleep scoring methods using advanced signal processing and machine learning approaches to analyze polysomnography signals have been widely developed and can achieve good agreement against consensus-based traditional human scoring (Fiorillo et al., 2019). However, most of the focus has been on reproducing existing manual approaches (Tsinalis et al., 2016; Supratak et al., 2017; ; Olesen et al., 2021). Thus, while these approaches are more standardized and time efficient, the fundamental limitations of traditional sleep metrics remain. Robust evidence to support causal relationships and clinical utility of most existing sleep metrics also remains sparse. Thus, the finer-grained quantifiable features within polysomnography data that may ultimately be more informative regarding underlying sleep mechanisms and quality continue to be largely ignored.
For example, EEG delta waves are tightly coupled in time and precede pulsatile changes in cerebral blood volume and cerebrospinal fluid flow during deep sleep (Fultz et al., 2019). Furthermore, a single night without sleep in healthy volunteers leads to β-amyloid accumulation (Shokri-Kojori et al., 2018). These findings support that delta waves during deep NREM sleep are a major driver of glymphatic clearance of metabolites from the central nervous system (; ). Wake/sleep transitions, such as potentially fatal microsleeps while driving, and a range of other physiological changes during sleep also occur on shorter timescales than assessed through traditional manual sleep scoring methods. For example, traditional scoring most likely misses potentially clinically informative neurophysiological features of synaptic downscaling, re-organization, memory and learning processes thought to occur during NREM and REM sleep (Tononi and Cirelli, 2006). Thus, conventional sleep scoring can only provide relatively superficial insights into brain activity and other physiological changes during sleep that are unlikely to be as sensitive or specific to underlying mechanisms as shorter-time scale features of sleep. Accordingly, a more physiologically guided, top-down measurement approach is clearly needed to provide greater neurobiological insight into sleep health and disease, and how sleep disturbance features relate to clinically relevant outcomes (Léger et al., 2018).
Defining evidence-based electrophysiological sleep markers is important in the age of precision medicine, particularly following rapid growth in minimally intrusive recording and consumer wearable devices that allow for sleep-related monitoring over prolonged periods in the home environment (Liu et al., 2017; Kim et al., 2019). These and other emerging technologies are likely to change many aspects of polysomnography, such as via printed electrodes (Norton et al., 2015) or tripolar concentric ring EEG (), by helping to uncover aspects of sleep health not routinely measured. For example, markers of circadian misalignment are technically difficult to monitor, so remain notably absent from conventional sleep studies. Emerging evidence highlights the potential to estimate circadian phase using non-intrusive physiological data such as skin temperature, heart rate variability and activity (Suárez et al., 2020; ). Blood pressure surges along with vasoconstriction and heart rate responses occur frequently during sleep, especially with swallowing (), but are not currently routinely captured or assessed. Continuous measurement of a range of biomarkers such as cortisol secretion during sleep through skin sensor devices (Parlak et al., 2018) may also have clinical utility.
Together, a range of new and emerging devices could routinely generate large volumes of sleep measurements over extended periods. This approach will require evidence to support clinical use and value, and software tools to assist clinicians to assess, analyze, and interpret sleep-omics (Redline and Purcell, 2021). To increase the uptake of new technologies in research and clinical settings, greater communication between sleep medicine experts and device manufacturers is needed. Rigorous standards for validation and evidence-based advances in medicine are required to ensure that new methods provide clinically useful insights that effectively and cost-effectively improve key patient outcomes (). While not a complete list of all available approaches, the sections below highlight several examples of existing approaches and notable promising new and emerging methods based on underlying pathophysiology/neurobiology to move beyond key limitations of current sleep metrics. A schematic representation of some of these examples is provided in Figure 2.
FIGURE 2
Key Components of the Polysomnographic
Electroencephalography
This review focuses on novel sleep metrics derived from EEG collected clinically using routine polysomnography. Other reviews regarding potential neurobiological insights of sleep physiology and circadian rhythms through high density EEG and intra-cranial/depth EEG are available elsewhere (Mosqueiro et al., 2014; Saper and Fuller, 2017; Scammell et al., 2017).
Slow Waves
Slow waves (0.5–4.5 Hz) are the main feature of deep sleep and one of the fundamental electrophysiological features of synchronous neuronal “down states” of relative neuronal inactivity and “up states” as activity resumes (Nir et al., 2011). These waves are thought to play a major role in synaptic recovery and down-scaling to compensate for daily high neuronal activity and synaptic potentiation during wake (Tononi and Cirelli, 2006) and glymphatic system removal of metabolic waste products from the central nervous system (; ). Slow waves are ubiquitous during sleep, and decrease in quantity and magnitude with age (). Several techniques have been developed to study specific aspects of slow waves, such as slow wave slope, absolute power, amplitude and phase in response to a range of experimental or naturalistic (e.g., aging) conditions (Massimini et al., 2004; ; Lazar et al., 2015; Lendner et al., 2020; Djonlagic et al., 2021). For example, the slope of half slow-waves (i.e., the slope between the up- and down-states) and slow wave amplitude/absolute power increase with sleep restriction and decrease with circadian phase, suggesting that sleep need and circadian rhythms have an effect on the shape and distribution of slow oscillations (Massimini et al., 2004; ; Lazar et al., 2015). Using the same features, reduced slow oscillations during sleep (low amplitude/absolute power) have recently been associated with poorer cognitive performance on a digit symbol coding test and the Trails B test in a large cross-sectional study of ∼3800 participants (Djonlagic et al., 2021). Many of these tools are available in open-source packages. With standardization, clinical validation and implementation, these novel metrics have substantial potential to provide unique insight into inter-individual vulnerability to specific health consequences in people with sleep disruption (Léger et al., 2018).
K-complexes
K-complexes are a form of isolated slow waves that provide unique insight into sleep stability and sleep disruption. They can occur spontaneously during sleep. However, K-complexes can also provide a sensitive marker of sensory disturbance to noise, respiratory and vibratory stimuli during sleep (; Scott et al., 2020; Lechat et al., 2021). Abnormal K-complex morphology (lower amplitude) and lower K-complex density (# per minutes) have been associated with the progression of amnestic mild cognitive impairment (pre-clinical phase of Alzheimer’s disease) in ∼70 patients (Liu et al., 2020). Abnormal K-complex morphology has also been associated with greater lapses in next-day alertness as measured using a psychomotor vigilance task (Parekh et al., 2019, 2021). At a population level, cross-sectional studies have suggested that a decrease in K-complex density may be a biomarker of sleep disorders, such as sleep apnea (Lechat et al., 2020). Further evidence regarding the functional significance of K-complexes is still emerging and warrants future investigation. This is likely to be facilitated via recent open-source tool developments (Parekh et al., 2015; Lechat et al., 2020).
Sleep Spindles
Sleep spindles are bursts of 11–15 Hz EEG activity and are another characteristic feature of NREM sleep that may provide a useful biomarker of sleep regulation and cognitive functioning (; Djonlagic et al., 2021). Sleep spindles are influenced by genetics and vary widely across the lifespan and different demographics (Purcell et al., 2017). Higher spindle occurrence (and density) have been associated with better memory performance and vigilance (Lafortune et al., 2014; Hennies et al., 2016) in cross-sectional studies with moderate sample sizes (n < 100). In a clinical population of 47 patients with obstructive sleep apnea (OSA), greater sleep spindle activity was associated with better implicit learning (Stevens et al., 2021). A recent analysis of two large US-cohorts (n∼3800) also supported an association between higher spindle occurrence and spindle power with greater performance on multiple cognitive tests (Djonlagic et al., 2021). In addition, the coupling (proximity and phase differences) between slow oscillations and spindles was also predictive of cognitive performance, further supporting a role of spindles in memory formation (Hahn et al., 2020) and consolidation (Helfrich et al., 2019; Muehlroth et al., 2019). Together, these results may explain, at least in part, the association between abnormal spindle activity during sleep and neurodegenerative diseases such as Alzheimer’s disease (Gorgoni et al., 2016) and Parkinson’s diseases (). However, spindle detection is still a challenge and algorithm refinements on public benchmark datasets remain warranted (Warby et al., 2014; Lacourse et al., 2020). Furthermore, recent evidence suggests that the current definition of sleep spindles may be too restrictive and traditionally defined spindles may only be a small subset of a more generalized class of sigma oscillations during sleep ().
Fourier-Based Analysis of Sleep Signals: Quantitative Electroencephalography
Sleep EEG is ideally suited to frequency and time-frequency analysis, since different stages or micro-elements (such as spindles, K-complexes, slow waves) have specific frequency characteristics (Steriade, 2006; Scammell et al., 2017), as shown in Figure 3. Power spectral analysis of EEG (sometimes referred to as quantitative EEG [qEEG]) provides a more sensitive and objective marker of neurophysiological features of sleep, some of which may be unique to specific patient phenotypes. For example, several studies have used qEEG to calculate the mean absolute power of given frequency bands (delta, alpha, theta, sigma, and beta), usually averaged over NREM and REM sleep, some of which have been shown to be predictive of insomnia (Krystal et al., 2002; Krystal and Edinger, 2010; Lunsford-Avery et al., 2021; Zhao et al., 2021) and OSA (D’Rozario et al., 2017; ). Emerging evidence also suggests that qEEG markers are associated with vigilance and cognitive performance (Vakulin et al., 2016; Djonlagic et al., 2021; Mullins et al., 2021).
FIGURE 3
The Odds Ratio Product
The odds ratio product (ORP) is a novel EEG-derived metric that provides a continuous index of sleep depth and alertness (Younes et al., 2015; Younes and Hanly, 2016). ORP is calculated as a ratio of absolute power of different frequency bands over 3-s segments. The ratio ranges from 0 to 2.5, where 0 indicates very deep sleep and 2.5 is wide awake, and correlates well with the visual appearance of EEG across the night (Younes et al., 2015, 2020). ORP derived metrics may be useful for a wide range of clinical applications, such as phenotyping sleep disorders and associated health consequences (Younes and Giannouli, 2020; ; Younes et al., 2021). For example, sleep depth coherence between C3 and C4 channels measured using the ORP is associated with risk of motor vehicle crashes (). A higher ORP during NREM sleep is also associated with the presence of OSA and insomnia, consistent with a more “alert” brain during NREM sleep in people with OSA and insomnia (Younes et al., 2021).
Scale-Free/Rapid Eye Movement Biomarkers
The scale-free component of neural activity (sometimes called “background brain activity” or “1/f” activity) is a further EEG component that may be an important biomarker of arousal level in human sleep (Lendner et al., 2020). Consistent with neuronal homeostatic and synaptic reorganization activity that takes place during REM sleep, 1/f activity is higher during REM sleep episodes. This observation may be especially important given the lack of targeted metrics designed to capture key physiological features of REM sleep. Eye movements, theta waves and atonia components require further investigation to test for relationships more comprehensively against other markers of REM sleep homeostasis and key clinical outcomes.
A limitation of all current biomarkers is the reliance on traditional manual scoring to express and evaluate summary values against conventional metrics with uncertain relationships with clinical endpoints. For example, absolute delta power, or ORP values, are usually averaged in NREM sleep. Spindles may be only detected in N2 sleep, and K-complex densities calculated in N2 and N3 sleep do not consider fluctuations in neurophysiological features across sleep cycles. EEG dynamics across sleep cycles are highly likely to be regulated by physiological processes such as circadian rhythms, brain metabolism, motor control learning, and memory consolidation processes (e.g., Figure 4). While averaging over traditionally scored sleep stages is convenient, it likely masks more subtle and potentially functionally important sleep-dependent changes over both short (<30 s) and longer cumulative time scales (minutes or hours). Secondly, current clinical utility of these biomarkers has mainly been studied cross-sectionally. Thus, well-designed randomized trials to investigate their potential additive benefit to sleep disorders management to improve health outcomes is warranted. Thirdly, methodologies used to calculate qEEG, ORP and other more fine-grained EEG elements are not standardized across research groups. Some methods are also not available under common license terms and therefore, independent cross-validation remains challenging.
FIGURE 4
Oxygenation Measures
Pulse oximeters can continuously and minimally intrusively estimate blood hemoglobin oxygen saturation (SpO2) and are an almost ubiquitous device in the hospital environment (Jubran, 2004). Overnight pulse oximetry also provides a key requisite measure for the evaluation of sleep apnea (Netzer et al., 2001; Terrill, 2020). Standard traditional time-series measures derived from the oxygen saturation signal include mean and nadir overnight SpO2, time spent below SpO2 of 90% and the oxygen desaturation index (ODI), typically calculated as the number of 3 or 4% desaturations below baseline levels per hour of sleep. However, these metrics have their limitations and agreed standards for their calculation remain lacking. For example, the ODI is partly dependent on the criteria used to define SpO2 dip onsets, offsets, and duration. The ODI also only reflects the frequency of hypoxemic events and fails to reflect the degree and duration of hypoxemia and further oxidative stress through rapid reoxygenation (Punjabi et al., 2008). The physiological consequence of a 3 or 4% drop is also likely dependent on the baseline saturation level and temporal pattern of desaturation which can vary widely between individuals and comorbidities (). Nonetheless, worse overnight hypoxemia derived from these traditional metrics has been associated with adverse health outcomes, such as increased blood pressure (Pengo et al., 2016; Su et al., 2021) and more recently atrophy of cortical and subcortical brain areas (Marchi et al., 2020). However, relationships with traditional hypoxia measures and important health/physiological outcomes are often weak, with inconsistent reproducibility between studies and cohorts (Pretto et al., 2014; ; Linz et al., 2020; Terrill, 2020).
Other non-traditional parameters from SpO2 such as the delta index measures the mean absolute difference between successive points at constant time intervals (Levy et al., 1996; Magalang et al., 2003; Lin et al., 2009), saturation impairment index computed as the time integral over which SpO2 is below certain threshold levels (i.e., baseline, 90, 80, 70, 60, and 50% saturation) (Kirby et al., 1992), and the hypoxic burden index computed as the area under the time versus desaturation curve (SpO2 < 90%) divided by total sleep time (; ) have been derived and used in research settings. Some of these parameters have been associated with important health outcomes. For example, hypoxic burden measures that incorporate frequency, duration and magnitude of hypoxemia have recently been shown to predict cardiovascular disease mortality in different cohorts, whereas traditional PSG metrics such as the AHI and ODI do not (; ). Quantification of an easily measured index of sleep apnea-related hypoxemia has recently been used to predict incident heart failure (). Accordingly, there remains considerable scope to better understand the precise mechanisms and characteristics by which hypoxemic and reoxygenation events during sleep contribute to cardiovascular and other end-organ damage, and to derive sensitive metrics to quantify these and other important health consequences. These recent findings highlight the potential for improvement beyond current traditional metrics. Through pulsatile changes in light absorption, oximeters can also provide potentially clinically useful markers of vasoconstriction responses during sleep (; Jordan et al., 2003) that may be clinically useful predictors of cardiovascular risk (Hirotsu et al., 2020).
Autonomic Signals
Assessment of autonomic nervous system activity during sleep is facilitated using photoplethysmography and ECG. The use of these signals in sleep medicine including new analytical methods and the potential insights they can provide has been covered in recent in-depth reviews (Fischer and Penzel, 2019; Ucak et al., 2021).
High increases in heart rate following apneic events are associated with 30–60% increases in mortality risk and non-fatal/fatal cardiovascular disease compared to normal heart rate responses (). New evidence also suggests that heart rate variability during wakefulness could be a useful marker of OSA severity and excessive daytime sleepiness, whereby OSA severity is associated with reduced and less complex dynamics of heart rate variability (Qin et al., 2021). Pulse wave amplitude (a marker of vasoconstriction in the finger) features (e.g., amplitude, frequency) have been associated with hypertension, cardiovascular events and diabetes (Hirotsu et al., 2020). Similarly, a decrease in pulse arrival time (time delay of pulse propagation between two points such as heart and finger) as a result of apneic events, is a predictor of subclinical cardiovascular disease and future cardiovascular events (Kwon et al., 2021). Pulse wave amplitude and heart rate responses are also sensitive markers to sensory disturbances during sleep such as noise (; Griefahn et al., 2008) and may therefore provide unique insights into downstream health effect of environmental sleep disturbances.
Signal Coupling and Other Approaches
While an exhaustive list of sleep metrics is not the objective of this review, and recent detailed reviews are available elsewhere (Mendonça et al., 2019; Lim et al., 2020), a few key metrics warrant brief coverage.
Motor system disorders such as periodic limb movement (PLM) and REM sleep behavior disorders (RBD) are associated with adverse outcomes. For example, PLMs are associated with stroke and cardiovascular risk factors in certain patient populations (Lindner et al., 2012). RBD may be an early biomarker of subsequent synucleinopathies such as Parkinson’s disease () and may increase the risk of stroke (Ma et al., 2017). RBD in people with Parkinson’s disease is also associated with faster motor progression and cognitive decline (Pagano et al., 2018). However, diagnosis of motor system disorders can be challenging. For example, screening questionnaires for RBD have variable sensitivity and specificity (Stiasny-Kolster et al., 2007; Li et al., 2010; ). Thus, there is a need for better diagnostic approaches for motor system disorders. These include leg actigraphy for PLMs (Plante, 2014), more standardized quantifiable approaches using EMG signals during polysomnography (Frauscher et al., 2012) and novel 3D video analysis approaches (Waser et al., 2020).
The cyclic alternating pattern (CAP) is an additional sleep scoring system beyond traditional AASM sleep scoring which aims to quantify NREM discontinuity by characterizing phases of activation (A phases) and periods of inactivity (B phases) (Terzano et al., 2001). Automatic methods of CAP scoring have been proposed (Hartmann and Baumert, 2019) and have been applied to study and define NREM instability in large population-based studies (; Hartmann et al., 2020) and may provide unique insight into sleep neurobiology. CAP and its potential utility is discussed in detail in recent comprehensive reviews (Mendonça et al., 2019; Lim et al., 2020).
Several research groups have investigated the coupling between multiple physiological signals, such as heart rate with respiratory signals (named cardio-pulmonary coupling) (Thomas et al., 2005, 2018; ; Penzel et al., 2016). Coupling-based analyses have also been applied between sleep EEG and heart rate (). The theoretical concept of coupling-functions between different physiological systems has been recently generalized under the framework of network physiology (; Ivanov et al., 2016). A more in-depth review of these techniques and their potential to provide insight into sleep neurobiology and consequences of impaired coupling is available in the literature (Ivanov et al., 2016; Penzel et al., 2016; ).
OSA Endotypes
The underlying causes of the most common sleep-related breathing disorder, OSA, vary considerably between patients. Current evidence indicates that there are at least four key pathophysiological “phenotypes,” more recently termed “endotypes,” that contribute to OSA pathophysiology (Eckert et al., 2013; Eckert, 2018a; Malhotra et al., 2020). While impaired pharyngeal anatomy is the most influential endotype, the magnitude of impaired pharyngeal anatomy varies widely between patients. In addition, approximately 70% of patients also have one or more non-anatomical endotypes that contribute to their OSA (Eckert et al., 2013; Eckert, 2018a). These include impaired pharyngeal dilator muscle function during sleep, unstable control of breathing (high loop gain) and waking up too easily to minor airway narrowing events during sleep (low respiratory arousal threshold) (Figure 5). These advances in knowledge in OSA pathophysiology have major implications for targeted therapy through “precision medicine.” For example, detailed physiological studies in which the key OSA endotypes have been quantified and non-CPAP interventions delivered to improve one or more of the non-anatomical treatable traits can reduce OSA severity (Eckert et al., 2011; Edwards et al., 2012, 2016b; Sands et al., 2018a; ; Taranto-Montemurro et al., 2019; Op de Beeck et al., 2021). Identification of patients with a low respiratory arousal threshold endotype may be an important physiological predictor of CPAP treatment failure (Gray et al., 2017; Zinchuk et al., 2021) and the presence of a low arousal threshold endotype is associated with mortality (). Similarly, identification of patients impairment in endotypes such as high loop gain and highly collapsible pharyngeal airways may be important predictors for non-CPAP treatment failure including upper airway surgery, mandibular advancement splint therapy, hypoglossal nerve stimulation, pharmacotherapy (Edwards et al., 2016a; Li et al., 2017; ; Op de Beeck et al., 2021) and potentially positional therapy (Eckert, 2018b).
FIGURE 5
However, current detailed physiological quantification of OSA endotypes is intrusive and far more complex and time-consuming to perform and analyze than standard polysomnography (Eckert, 2018a). Thus, this approach is impractical for clinical use. Accordingly, novel approaches to estimate the key OSA endotypes have been developed. These include more scalable advanced signal processing techniques (Sands et al., 2018a,b), machine learning approaches (Dutta et al., 2021) and algorithms (Edwards et al., 2014) which simply make better use of the existing rich neurophysiological and respiratory information acquired from diagnostic polysomnography recordings and standard clinical metrics such as age and BMI. Other strategies to estimate specific OSA endotypes include estimates based on a simple intervention during a CPAP titration study (Osman et al., 2020), the therapeutic CPAP level (Landry et al., 2017) and wakefulness upper airway physiology testing (Wang et al., 2018; Osman et al., 2019). These principles and recent proof-of-concept findings have opened multiple new lines of investigation for the development of more clinically feasible and scalable approaches to help better guide targeted therapy and precision medicine for OSA.
Circadian Rhythms
The Need to Assess Circadian Rhythms to Define Sleep Disruption
Aside from advances in PSG sleep and breathing metrics, new approaches are emerging in the assessment of circadian rhythms; another key determinant of sleep and its disorders (; ). These endogenous rhythms are ubiquitous, with nearly every cell in the human body influenced by a biological “clock.” The suprachiasmatic nucleus in the hypothalamus, colloquially termed the “master” clock, governs the timing of many circadian rhythms influential for sleep, including melatonin secretion, core body temperature (), gene transcription and translation regulated clock behavior of nucleated cells throughout the body (Kondratova and Kondratov, 2012). Even non-nucleated red blood cells show circadian cycling of redox activity (O’Neill and Reddy, 2011). The effects of circadian rhythms on sleep disruption are most evident in circadian rhythm sleep disorders, such as delayed and advanced sleep-wake phase disorder, shift-work disorder, and non-24-h sleep disorder where the circadian phase (timing relative to clock time), amplitude of the rhythm, and/or period (duration of the circadian cycle) are poorly aligned with wake activities and environmental time cues, leading to disrupted sleep (Micic et al., 2016; James et al., 2017). Fortunately, disrupted circadian rhythms are treatable to improve sleep (Dodson and Zee, 2010).
Given the major role of circadian rhythms in mediating sleep patterns and behavior, methods to assess circadian rhythms across the different manifestations of sleep disruption are likely to be insightful. In chronic insomnia, circadian rhythm factors may importantly contribute to the underlying etiology and pathophysiology (Lack et al., 2008). Chronobiological interventions, such as bright light therapy, have been administered as a stand-alone treatment and combined with CBT-I to moderate effect (Jankù et al., 2020). Circadian rhythms could also play a role in OSA (von Allmen et al., 2018) and comorbid insomnia and OSA (COMISA) (Sweetman et al., 2021). Effects of circadian rhythms on respiratory control (Stephenson, 2003; Yamauchi et al., 2014) and hypoxia (von Allmen et al., 2018) have also been hypothesized and supported by recent evidence of circadian modulation of the key OSA endotypes (El-Chami et al., 2014, 2015; Puri et al., 2020). Circadian rhythms also have an influential effect on metabolism, diabetes, cardiovascular disorders, obesity, and the efficacy of a range of pharmacological interventions; factors often applicable to sleep disorder cohorts (Guo and Stein, 2003; Frazier and Chang, 2020; ). Therefore, strategies to better define sleep disruption that incorporate circadian rhythm assessments have significant potential to improve diagnostic and targeted therapy outcomes.
Current and Emerging Methods to Assess Circadian Rhythms
The current “gold standard” measure of circadian rhythms is salivary or blood dim-light melatonin onset (; ). This method involves measuring the concentration of melatonin (in pmol/mL) via a blood draw or via half-hourly saliva samples for at least 3–4 h before bedtime, under dim-light conditions (light intensity < 10 lux) while the individual remains relatively stationary and avoids consuming food and drinks (Sletten et al., 2018). Samples are processed and analyzed to estimate the clock time of melatonin rise onset (>10 pmol/mL), which is a marker of circadian phase. Another common measure of circadian rhythms in sleep research is core body temperature via an ingestible capsule or rectal thermistor. Frequent sampling of temperature across an extended period (>24 h), where conditions and activities that affect body temperature are controlled (e.g., air temperature, body movement, food consumption, and hot drink consumption), enables assessment of several aspects of the underlying core body temperature rhythm, including circadian phase, amplitude, and period. However, these assessments require carefully controlled laboratory conditions and access to specialized equipment generally infeasible for routine administration outside of circadian rhythm-focused sleep research studies. Fortunately, technologies and analytical methodologies are emerging that promise to facilitate simpler and improved assessments of circadian rhythms.
Emerging methods include advanced monitoring devices and biomathematical modeling to infer circadian rhythm metrics (Reid, 2019). Newer technologies include skin temperature sensors incorporated into consumer sleep trackers that detect the peripheral temperature rhythm to estimate circadian phase (Hasselberg et al., 2013). Electronic chips that can be implanted in body patches are also being developed to assess the cortisol rhythm via sweat (Upasham and Prasad, 2020), as well as other important clinical indicators such as the cortisol awakening response (Law and Clow, 2020). Rather than direct assessment of circadian rhythms, another approach is to infer circadian timing via the measurement of factors associated with circadian rhythms. Sleep timing data collected from wearable and non-wearable sleep trackers over an extended period are being incorporated into biomathematical models to infer circadian timing, since rest-activity rhythms are highly correlated with circadian timing (). Light sensors incorporated into newer wearable devices are also being used to infer circadian timing (Stone et al., 2020), since light is the strongest exogenous influencer (zeitgeber) of circadian rhythms. This information, potentially coupled with pupillometry assessment of an individual’s retinal responsiveness to light, enables inference of circadian timing, which may be useful for the diagnosis of circadian disruption in sleep disorders. More recent discoveries of genes with circadian oscillations (clock-controlled genes) raises the possibility that certain aspects of circadian rhythms may be amenable to assessment from blood samples (). As these newer technologies mature, their implementation in clinical and research practice may result in new discoveries regarding the role of circadian rhythms in sleep disorders and their health-related consequences.
Novel Measures of Environmental Factors That Can Affect Sleep
The sleeping environment affects sleep ability, but is minimally assessed in routine clinical practice. Consequently, sleep disruption may be misattributed to endogenous factors alone, ignoring the potential impact of exogenous factors. These include noise, light, temperature, and other factors that impact comfort within the sleep context. In a laboratory environment, these factors are typically well-controlled and designed to be conducive for sleep. However, as the assessment of sleep disruption shifts from the laboratory to the less well-controlled home environment, the assessment and consideration of environmental factors becomes increasingly important to understand mechanisms of sleep disruption.
Potentially the strongest exogenous influencer of sleep is noise, which can adversely affect sleep attainment and maintenance and fragment sleep to reduce total sleep time and quality (Muzet, 2007; ). The most common self-reported outcomes in response to road, rail and aircraft noise exposure are awakenings from sleep, increased sleep latency, and disruption to sleep continuity (). For example, patients in hospital intensive care units consistently rate noise as the most sleep disturbing factor (Freedman et al., 2001; Gabor et al., 2003; Elliott et al., 2013) and polysomnography results indicate poor and fragmented sleep, with a median of only 5 h sleep/24 h, only 3 min of uninterrupted light sleep and almost total abolition of deep and REM sleep (Elliott et al., 2014). However, to date, noise is rarely assessed as a potential sleep disturbing factor in either clinical or home setting contexts. Studies that have investigated the effects of noise on sleep quality have employed generalized metrics that focus on overall noise levels only and/or do not consider specific noise characteristics such as spectral content, time varying noise components, tonality and noise intermittency. These factors are important contributors to noise annoyance (Ioannidou et al., 2016; Schäffer et al., 2016; Oliva et al., 2017), are thus likely to contribute to sleep disturbance, and warrant assessment to better inform clinical decision-making.
Scalable Approaches to Measure Sleep Including Multi-Night Assessments
There are two seemingly opposing challenges regarding sleep monitoring and diagnostics. There is a need for greater in-depth insight into the underlying neurobiology of sleep, yet there is also a need for less intrusive and user-friendly technology. Detailed, in-depth assessments and monitoring approaches as well as smarter use of existing signals and information derived from traditional polysomnography approaches are required to better understand sleep pathology. Yet, given the burden of disease and the scale of sleep disruption in the community, there is also a pressing need for less intrusive sleep tracking technology that can be readily and easily adopted in a home-based setting.
A plethora of technologies have emerged to track sleep in the home setting (Figure 6). These include bedside Doppler (Zakrzewski et al., 2015; Tuominen et al., 2019) and instrumented mattresses for ballistographic assessment of heart rate, respiratory rate and body movements/position, which perform relatively well compared to polysomnography and are considerably easier to implement and use (Laurino et al., 2020). Similarly, wearable devices such as smart watches, rings, simplified EEG headbands, and actigraphy devices also provide similar performance in sleep/wake assessment (Griessenberger et al., 2013; ; ; ; Scott et al., 2021). Infrared video has also been used to classify body motion to automatically score sleep and wake states (Wang et al., 2013), as well as monitor respiration, head posture, and body posture to detect abnormal breathing (). Together, these devices open new pathways for non-invasive multi-night assessments in various sleep settings to support the clinical diagnosis and management of sleep disorders. This is especially important given that sleep disorder pathophysiology may show large variability between nights (Punjabi et al., 2020), and that variability and irregularity in some sleep components has been associated with downstream effects on health such as cardio-metabolic conditions (Linz et al., 2019a,b; Huang et al., 2020).
FIGURE 6
Final Summary/Conclusion
New and emerging approaches to better define sleep and circadian disruption and its consequences offers considerable promise to move beyond the limitations of current sleep metrics and management. To improve outcomes, these approaches need to be underpinned by consideration for underlying neurobiology and will likely require a multisystem approach to capture the diverse impacts that sleep and circadian disruption can have on health and wellbeing. Development of practical, inexpensive methods to assess sleep and circadian disruption, its key contributors, and consequences at scale, including comprehensive, long-term remote monitoring has the potential to transform sleep medicine and management. This includes implementation of precision sleep medicine and targeted therapy approaches.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Author contributions
All authors contributed to drafting and/or revising one or more of the sections of this manuscript, provided feedback on the final version, and agreed to be accountable for the content of the work.
Funding
KH was supported by an Australian Research Council Discovery Early Career Researcher Award (DE180100022). AV was supported by a National Health and Medical Research Council (NHMRC) of Australia Career Development Fellowship (1159499). DE was supported by a NHMRC of Australia Senior Research Fellowship (1116942) and an Investigator Grant (1196261). BL was supported by the Nick Antic Sleep Research Scholarship from Flinders Foundation. This was an investigator-initiated, non-commercially funded study.
Conflict of interest
DE has a Collaborative Research Centre (CRC-P) Grant, a consortium grant between the Australian Government, Academia and Industry (Industry partner: Oventus Medical) and has research grants and serves as a consultant for Bayer and Apnimed. AV has received research grant funding and equipment from ResMed and Philips Respironics. PC has received research funding from Defence Science and Technology and received research grant funding and equipment from Philips Respironics. The funders Philips Respironics, ResMed, Oventus Medical, Bayer, Apnimed were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AdamsR. J.AppletonS. L.VakulinA.LangC.MartinS. A.TaylorA. W.et al (2016). Association of daytime sleepiness with obstructive sleep apnoea and comorbidities varies by sleepiness definition in a population cohort of men.Respirology211314–1321. 10.1111/resp.12829
2
AishahA.EckertD. J. (2019). Phenotypic approach to pharmacotherapy in the management of obstructive sleep apnoea.Curr. Opin. Pulmonary Med.25594–601. 10.1097/MCP.0000000000000628
3
AppletonS. L.VakulinA.D’RozarioA.VincentA. D.TeareA.MartinS. A.et al (2019). Quantitative electroencephalography measures in rapid eye movement and nonrapid eye movement sleep are associated with apnea–hypopnea index and nocturnal hypoxemia in men.Sleep42:zsz092. 10.1093/sleep/zsz092
4
ArendtJ.BojkowskiC.FraneyC.WrightJ.MarksV. (1985). Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol.J. Clin. Endocrinol. Metab.601166–1173. 10.1210/jcem-60-6-1166
5
ArnalP. J.ThoreyV.DebellemaniereE.BallardM. E.Bou HernandezA.GuillotA.et al (2020). The Dreem Headband compared to polysomnography for electroencephalographic signal acquisition and sleep staging.Sleep43:zsaa097. 10.1093/sleep/zsaa097
6
AyacheM.StrohlK. P. (2018). High interrater reliability of overnight pulse oximetry interpretation among inexperienced physicians using a structured template.J. Clin. Sleep Med.14541–548. 10.5664/jcsm.7040
7
AyyarV. S.SukumaranS. (2021). Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions.J. Pharmacokinet. Pharmacodyn.48321–338. 10.1007/s10928-021-09751-2
8
AzarbarzinA.SandsS. A.StoneK. L.Taranto-MontemurroL.MessineoL.TerrillP. I.et al (2019). The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study.Eur. Heart J.401149–1157. 10.1093/eurheartj/ehy624
9
AzarbarzinA.SandsS. A.Taranto-MontemurroL.VenaD.SoferT.KimS.-W.et al (2020). The sleep apnea-specific hypoxic burden predicts incident heart failure.Chest158739–750. 10.1016/j.chest.2020.03.053
10
AzarbarzinA.YounesM.SandsS. A.WellmanA.RedlineS.CzeislerC. A.et al (2021). Interhemispheric sleep depth coherence predicts driving safety in sleep apnea.J. Sleep Res.30:e13092. 10.1111/jsr.13092
11
BartschaR.SchumannA.KantelhardtJ. W.PenzelT.IvanovP. C. (2012). Phase transitions in physiologic coupling.Proc. Natl. Acad. Sci. U.S.A.910181–10186. 10.1073/pnas.1204568109
12
BashanA.BartschR.KantelhardtJ. W.HavlinS.IvanovP. C. (2012). Network physiology reveals relations between network topology and physiological function.Nat. Commun.3:702. 10.1038/ncomms1705
13
BasnerM.BabischW.DavisA.BrinkM.ClarkC.JanssenS.et al (2014). Auditory and non-auditory effects of noise on health.Lancet3831325–1332. 10.1016/S0140-6736(13)61613-X
14
BasnerM.McGuireS. (2018). WHO environmental noise guidelines for the European region: a systematic review on environmental noise and effects on sleep.Int. J. Environ. Res. Public Health15:519. 10.3390/ijerph15030519
15
BaumertM.ImmanuelS. A.StoneK. L.Litwack HarrisonS.RedlineS.MarianiS.et al (2020). Composition of nocturnal hypoxaemic burden and its prognostic value for cardiovascular mortality in older community-dwelling men.Eur. Heart J.41533–541. 10.1093/eurheartj/ehy838
16
BenjafieldA. V.AyasN. T.EastwoodP. R.HeinzerR.IpM. S.MorrellM. J.et al (2019). Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis.Lancet Respiratory Med.7687–698. 10.1016/S2213-2600(19)30198-5
17
BenloucifS.BurgessH. J.KlermanE. B.LewyA. J.MiddletonB.MurphyP. J.et al (2008). Measuring melatonin in humans.J. Clin. Sleep Med.466–69. 10.5664/jcsm.27083
18
BenvenisteH.ElkinR.HeerdtP. M.KoundalS.XueY.LeeH.et al (2020). The glymphatic system and its role in cerebral homeostasis.J. Appl. Physiol.1291330–1340. 10.1152/japplphysiol.00852.2019
19
BerryR. B.BrooksR.GamaldoC.HardingS. M.LloydR. M.QuanS. F.et al (2017). AASM Scoring Manual Updates for 2017 (version 2.4).Darien, IL: American Academy of Sleep Medicine. 10.5664/jcsm.6576
20
BersagliereA.AchermannP. (2010). Slow oscillations in human non-rapid eye movement sleep electroencephalogram: effects of increased sleep pressure.J. Sleep Res.19228–237. 10.1111/j.1365-2869.2009.00775.x
21
BesioW.AakulaR.KokaK.DaiW. (2006). Development of a tri-polar concentric ring electrode for acquiring accurate Laplacian body surface potentials.Ann. Biomed. Eng.34426–435. 10.1007/s10439-005-9054-8
22
BoeveB. F.MolanoJ. R.FermanT. J.SmithG. E.LinS.-C.BieniekK.et al (2011). Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort.Sleep Med.12445–453. 10.1016/j.sleep.2010.12.009
23
BorbélyA. A. (1982). A two process model of sleep regulation.Hum. Neurobiol.1195–204.
24
BrandenbergerG.EhrhartJ.PiquardF.SimonC. (2001). Inverse coupling between ultradian oscillations in delta wave activity and heart rate variability during sleep.Clin. Neurophysiol.112992–996. 10.1016/S1388-2457(01)00507-7
25
BraunM.IliffJ. J. (2020). The impact of neurovascular, blood-brain barrier, and glymphatic dysfunction in neurodegenerative and metabolic diseases.Int. Rev. Neurobiol.154413–436. 10.1016/bs.irn.2020.02.006
26
BurkeP.CarterS.KnapmanF.PattiJ.ButlinM.GandeviaS.et al (2020). Nocturnal swallowing augments arousal intensity and arousal tachycardia.Proc. Natl. Acad. Sci.1178624–8632. 10.1073/pnas.1907393117
27
ButlerM. P.EmchJ. T.RueschmanM.SandsS. A.SheaS. A.WellmanA.et al (2019). Apnea-Hypopnea event duration predicts mortality in men and women in the sleep heart health study.Am. J. Respir. Crit. Care Med.199903–912. 10.1164/rccm.201804-0758OC
28
BuysseD. J.HallM. L.StrolloP. J.KamarckT. W.OwensJ.LeeL.et al (2008). Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical/polysomnographic measures in a community sample.J. Clin. Sleep Med.4563–571. 10.5664/jcsm.27351
29
BuysseD. J.YuL.MoulD. E.GermainA.StoverA.DoddsN. E.et al (2010). Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments.Sleep33781–792. 10.1093/sleep/33.6.781
30
CajochenC.KräuchiK.Wirz-JusticeA. (2003). Role of melatonin in the regulation of human circadian rhythms and sleep.J. Neuroendocrinol.15432–437. 10.1046/j.1365-2826.2003.00989.x
31
CarberryJ. C.AmatouryJ.EckertD. J. (2018). Personalized management approach for OSA.Chest153744–755. 10.1016/j.chest.2017.06.011
32
CatchesideP. G.ChiongS. C.OrrR. S.MercerJ.SaundersN. A.McEvoyR. D. (2001). Acute cardiovascular responses to arousal from non-REM sleep during normoxia and hypoxia.Sleep24895–902. 10.1093/sleep/24.8.895
33
CatchesideP. G.OrrR. S.ChiongS. C.MercerJ.SaundersN. A.McEvoyR. D. (2002). Noninvasive cardiovascular markers of acoustically induced arousal from non–rapid-eye-movement sleep.Sleep25797–804. 10.1093/sleep/25.7.797
34
ChambonS.GaltierM. N.ArnalP. J.WainribG.GramfortA. (2018). A deep learning architecture for temporal sleep stage classification using multivariate and multimodal time series.IEEE Trans. Neural Syst. Rehabil. Eng.26758–769. 10.1109/TNSRE.2018.2813138
35
CheeN. I.GhorbaniS.GolkashaniH. A.LeongR. L.OngJ. L.CheeM. W. (2021). Multi-night validation of a sleep tracking ring in adolescents compared with a research actigraph and polysomnography.Nat. Sci. Sleep13:177. 10.2147/NSS.S286070
36
ChengP.WalchO.HuangY.MayerC.SagongC.Cuamatzi CastelanA.et al (2021). Predicting circadian misalignment with wearable technology: validation of wrist-worn actigraphy and photometry in night shift workers.Sleep44:zsaa180. 10.1093/sleep/zsaa180
37
ChinoyE. D.FreyD. J.KaslovskyD. N.MeyerF. G.WrightK. P.Jr. (2014). Age-related changes in slow wave activity rise time and NREM sleep EEG with and without zolpidem in healthy young and older adults.Sleep Med.151037–1045. 10.1016/j.sleep.2014.05.007
38
ChristensenJ. A.NikolicM.WarbyS. C.KochH.ZoetmulderM.FrandsenR.et al (2015). Sleep spindle alterations in patients with Parkinson’s disease.Front. Hum. Neurosci.9:233. 10.3389/fnhum.2015.00233
39
ClaassenD. O.JosephsK. A.AhlskogJ. E.SilberM. H.Tippmann-PeikertM.BoeveB. F. (2010). REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.Neurology75494–499. 10.1212/WNL.0b013e3181ec7fac
40
CogswellD.BisesiP.MarkwaldR.Cruickshank-QuinnC.QuinnK.McHillA.et al (2020). 0050 identification of a plasma metabolome-based biomarker for dim-light melatonin offset and onset in humans.Sleep43(Suppl. 1)A20–A21. 10.1093/sleep/zsaa056.049
41
ColrainI. M. (2005). The K-complex: a 7-decade history.Sleep28255–273. 10.1093/sleep/28.2.255
42
DaanS.BeersmaD.BorbélyA. A. (1984). Timing of human sleep: recovery process gated by a circadian pacemaker.Am. J. Physiol.-Regulat., Integrat. Comparat. Physiol.246R161–R183. 10.1152/ajpregu.1984.246.2.R161
43
de ZambottiM.TrinderJ.SilvaniA.ColrainI. M.BakerF. C. (2018b). Dynamic coupling between the central and autonomic nervous systems during sleep: a review.Neurosci. Biobehav. Rev.9084–103. 10.1016/j.neubiorev.2018.03.027
44
de ZambottiM.GoldstoneA.ClaudatosS.ColrainI. M.BakerF. C. (2018a). A validation study of Fitbit Charge 2TM compared with polysomnography in adults.Chronobiol. Int.35465–476. 10.1080/07420528.2017.1413578
45
DengF.DongJ.WangX.FangY.LiuY.YuZ.et al (2018). Design and implementation of a noncontact sleep monitoring system using infrared cameras and motion sensor.IEEE Trans. Instrument. Measurement671555–1563. 10.1109/TIM.2017.2779358
46
DepnerC. M.ChengP. C.DevineJ. K.KhoslaS.De ZambottiM.RobillardR.et al (2020). Wearable technologies for developing sleep and circadian biomarkers: a summary of workshop discussions.Sleep43:zsz254. 10.1093/sleep/zsz254
47
DiekelmannS.BornJ. (2010). The memory function of sleep.Nat. Rev. Neurosci.11114–126. 10.1038/nrn2762
48
DimitrovT.HeM.StickgoldR.PrerauM. J. (2021). Sleep spindles comprise a subset of a broader class of electroencephalogram events.Sleep44:zsab099. 10.1093/sleep/zsab099
49
DjonlagicI.MarianiS.FitzpatrickA. L.Van Der KleiV. M.JohnsonD. A.WoodA. C.et al (2021). Macro and micro sleep architecture and cognitive performance in older adults.Nat. Hum. Behav.5123–145. 10.1038/s41562-020-00964-y
50
DodsonE. R.ZeeP. C. (2010). Therapeutics for circadian rhythm sleep disorders.Sleep Med. Clinics5701–715. 10.1016/j.jsmc.2010.08.001
51
D’RozarioA. L.CrossN. E.VakulinA.BartlettD. J.WongK. K.WangD.et al (2017). Quantitative electroencephalogram measures in adult obstructive sleep apnea–potential biomarkers of neurobehavioural functioning.Sleep Med. Rev.3629–42. 10.1016/j.smrv.2016.10.003
52
DuttaR.DelaneyG.TosonB.JordanA. S.WhiteD. P.WellmanA.et al (2021). A novel model to estimate key obstructive sleep apnea endotypes from standard polysomnography and clinical data and their contribution to obstructive sleep apnea severity.Ann. Am. Thoracic Soc.18656–667. 10.1513/AnnalsATS.202001-064OC
53
EckertD. J. (2018a). Phenotypic approaches to obstructive sleep apnoea–new pathways for targeted therapy.Sleep Med. Rev.3745–59. 10.1016/j.smrv.2016.12.003
54
EckertD. J. (2018b). Phenotypic approaches to positional therapy for obstructive sleep apnoea.Sleep Med. Rev.37175–176. 10.1016/j.smrv.2017.06.007
55
EckertD. J.OwensR. L.KehlmannG. B.WellmanA.RahangdaleS.Yim-YehS.et al (2011). Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold.Clin. Sci.120505–514. 10.1042/CS20100588
56
EckertD. J.WhiteD. P.JordanA. S.MalhotraA.WellmanA. (2013). Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets.Am. J. Respiratory Critical Care Med.188996–1004. 10.1164/rccm.201303-0448OC
57
EdwardsB. A.SandsS. A.OwensR. L.EckertD. J.LandryS.WhiteD. P.et al (2016b). The combination of supplemental oxygen and a hypnotic markedly improves obstructive sleep apnea in patients with a mild to moderate upper airway collapsibility.Sleep391973–1983. 10.5665/sleep.6226
58
EdwardsB. A.AndaraC.LandryS.SandsS. A.JoostenS. A.OwensR. L.et al (2016a). Upper-Airway collapsibility and loop gain predict the response to oral appliance therapy in patients with obstructive sleep apnea.Am. J. Respir. Crit. Care Med.1941413–1422. 10.1164/rccm.201601-0099OC
59
EdwardsB. A.EckertD. J.McSharryD. G.SandsS. A.DesaiA.KehlmannG.et al (2014). Clinical predictors of the respiratory arousal threshold in patients with obstructive sleep apnea.Am. J. Respiratory Crit. Care Med.1901293–1300. 10.1164/rccm.201404-0718OC
60
EdwardsB. A.SandsS. A.EckertD. J.WhiteD. P.ButlerJ. P.OwensR. L.et al (2012). Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea.J. Physiol.5901199–1211. 10.1113/jphysiol.2011.223925
61
El-ChamiM.ShaheenD.IversB.SyedZ.BadrM. S.LinH.-S.et al (2014). Time of day affects chemoreflex sensitivity and the carbon dioxide reserve during NREM sleep in participants with sleep apnea.J. Appl. Physiol.1171149–1156. 10.1152/japplphysiol.00681.2014
62
El-ChamiM.ShaheenD.IversB.SyedZ.BadrM. S.LinH.-S.et al (2015). Time of day affects the frequency and duration of breathing events and the critical closing pressure during NREM sleep in participants with sleep apnea.J. Appl. Physiol.119617–626. 10.1152/japplphysiol.00346.2015
63
ElliottR.McKinleyS.CistulliP.FienM. (2013). Characterisation of sleep in intensive care using 24-hour polysomnography: anobservational study.Crit. Care171–10. 10.1186/cc12565
64
ElliottR.RaiT.McKinleyS. (2014). Factors affecting sleep in the critically ill: an observational study.J. Crit. Care29859–863. 10.1016/j.jcrc.2014.05.015
65
FiorilloL.PuiattiA.PapandreaM.RattiP.-L.FavaroP.RothC.et al (2019). Automated sleep scoring: a review of the latest approaches.Sleep Med. Rev.48:101204. 10.1016/j.smrv.2019.07.007
66
FischerC.PenzelT. (2019). Continuous non-invasive determination of nocturnal blood pressure variation using photoplethysmographic pulse wave signals: comparison of pulse propagation time, pulse transit time and RR-interval.Physiol. Measurement40:014001. 10.1088/1361-6579/aaf298
67
FrauscherB.IranzoA.GaigC.GschliesserV.GuaitaM.RaffelsederV.et al (2012). Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder.Sleep35835–847. 10.5665/sleep.1886
68
FrazierK.ChangE. B. (2020). Intersection of the gut microbiome and circadian rhythms in metabolism.Trends Endocrinol. Metab.3125–36. 10.1016/j.tem.2019.08.013
69
FreedmanN. S.GazendamJ.LevanL.PackA. I.SchwabR. J. (2001). Abnormal sleep/wake cycles and the effect of environmental noise on sleep disruption in the intensive care unit.Am. J. Respiratory Crit. Care Med.163451–457. 10.1164/ajrccm.163.2.9912128
70
FultzN. E.BonmassarG.SetsompopK.StickgoldR. A.RosenB. R.PolimeniJ. R.et al (2019). Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep.Science366628–631. 10.1126/science.aax5440
71
GaborJ. Y.CooperA. B.CrombachS. A.LeeB.KadikarN.BettgerH. E.et al (2003). Contribution of the intensive care unit environment to sleep disruption in mechanically ventilated patients and healthy subjects.Am. J. Respiratory Crit. Care Med.167708–715. 10.1164/rccm.2201090
72
GorgoniM.LauriG.TrugliaI.CordoneS.SarassoS.ScarpelliS.et al (2016). Parietal fast sleep spindle density decrease in Alzheimer’s disease and amnesic mild cognitive impairment.Neural Plasticity2016:8376108. 10.1155/2016/8376108
73
GrayE. L.McKenzieD. K.EckertD. J. (2017). Obstructive sleep apnea without obesity is common and difficult to treat: evidence for a distinct pathophysiological phenotype.J. Clin. Sleep Med.: JCSM : Off. Public. Am. Acad. Sleep Med.1381–88. 10.5664/jcsm.6394
74
GriefahnB.BrödeP.MarksA.BasnerM. (2008). Autonomic arousals related to traffic noise during sleep.Sleep31569–577. 10.1093/sleep/31.4.569
75
GriessenbergerH.HeibD. P. J.KunzA.HödlmoserK.SchabusM. (2013). Assessment of a wireless headband for automatic sleep scoring.Sleep Breathing17747–752. 10.1007/s11325-012-0757-4
76
GuoY.-F.SteinP. K. (2003). Circadian rhythm in the cardiovascular system: chronocardiology.Am. Heart J.145779–786. 10.1016/S0002-8703(02)94797-6
77
HahnM. A.HeibD.SchabusM.HoedlmoserK.HelfrichR. F. (2020). Slow oscillation-spindle coupling predicts enhanced memory formation from childhood to adolescence.Elife9:e53730. 10.7554/eLife.53730.sa2
78
HartmannS.BaumertM. (2019). Automatic a-phase detection of cyclic alternating patterns in sleep using dynamic temporal information.IEEE Trans. Neural Syst. Rehabil. Eng.271695–1703. 10.1109/TNSRE.2019.2934828
79
HartmannS.BruniO.FerriR.RedlineS.BaumertM. (2020). Characterization of cyclic alternating pattern during sleep in older men and women using large population studies.Sleep43:zsaa016. 10.1093/sleep/zsaa016
80
HarveyA. G.TangN. K. (2003). Cognitive behaviour therapy for primary insomnia: can we rest yet?Sleep Med. Rev.7237–262. 10.1053/smrv.2002.0266
81
HasselbergM. J.McMahonJ.ParkerK. (2013). The validity, reliability, and utility of the iButton® for measurement of body temperature circadian rhythms in sleep/wake research.Sleep Med.145–11. 10.1016/j.sleep.2010.12.011
82
HelfrichR. F.LendnerJ. D.ManderB. A.GuillenH.PaffM.MnatsakanyanL.et al (2019). Bidirectional prefrontal-hippocampal dynamics organize information transfer during sleep in humans.Nat. Commun.101–16. 10.1038/s41467-019-11444-x
83
HenniesN.RalphM. A. L.KempkesM.CousinsJ. N.LewisP. A. (2016). Sleep spindle density predicts the effect of prior knowledge on memory consolidation.J. Neurosci.363799–3810. 10.1523/JNEUROSCI.3162-15.2016
84
HirotsuC.BettaM.BernardiG.Marques-VidalP.VollenweiderP.WaeberG.et al (2020). Pulse wave amplitude drops during sleep: clinical significance and characteristics in a general population sample.Sleep43:zsz322. 10.1093/sleep/zsz322
85
HuangT.MarianiS.RedlineS. (2020). Sleep irregularity and risk of cardiovascular events: the multi-ethnic study of atherosclerosis.J. Am. College Cardiol.75991–999. 10.1016/j.jacc.2019.12.054
86
IoannidouC.SanturetteS.JeongC.-H. (2016). Effect of modulation depth, frequency, and intermittence on wind turbine noise annoyance.J. Acoustical Soc. Am.1391241–1251. 10.1121/1.4944570
87
IvanovP. C.LiuK. K.BartschR. P. (2016). Focus on the emerging new fields of network physiology and network medicine.New J. Phys.18:100201. 10.1088/1367-2630/18/10/100201
88
JamesS. M.HonnK. A.GaddameedhiS.Van DongenH. P. (2017). Shift work: disrupted circadian rhythms and sleep—implications for health and well-being.Curr. Sleep Med. Rep.3104–112. 10.1007/s40675-017-0071-6
89
JankùK.ŠmotekM.FárkováE.KopøivováJ. (2020). Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia.Chronobiol. Int.37248–259. 10.1080/07420528.2019.1692859
90
JordanA. S.EckertD. J.CatchesideP. G.McEvoyR. D. (2003). Ventilatory response to brief arousal from non–rapid eye movement sleep is greater in men than in women.Am. J. Respiratory Crit. Care Med.1681512–1519. 10.1164/rccm.200302-150OC
91
JubranA. (2004). Pulse oximetry.Intens. Care Med.302017–2020. 10.1007/s00134-004-2399-x
92
KimJ.CampbellA. S.de ÁvilaB. E.-F.WangJ. (2019). Wearable biosensors for healthcare monitoring.Nat. Biotechnol.37389–406. 10.1038/s41587-019-0045-y
93
KirbyS. C.AndersonW. M.ChessonA. L.GeorgeR. B. (1992). Computer quantitation of saturation impairment time as an index of oxygenation during sleep.Comput. Methods Programs Biomed.38107–115. 10.1016/0169-2607(92)90081-H
94
KondratovaA. A.KondratovR. V. (2012). The circadian clock and pathology of the ageing brain.Nat. Rev. Neurosci.13325–335. 10.1038/nrn3208
95
KrystalA. D.EdingerJ. D. (2010). Sleep EEG predictors and correlates of the response to cognitive behavioral therapy for insomnia.Sleep33669–677. 10.1093/sleep/33.5.669
96
KrystalA. D.EdingerJ. D.WohlgemuthW. K.MarshG. R. (2002). NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes.Sleep25626–636.
97
KwonY.WilesC.ParkerB. E.ClarkB. R.SohnM.-W.MarianiS.et al (2021). Pulse arrival time, a novel sleep cardiovascular marker: the multi-ethnic study of atherosclerosis.Thorax [Online ahead of print]10.1136/thoraxjnl-2020-216399
98
LackL. C.GradisarM.Van SomerenE. J.WrightH. R.LushingtonK. (2008). The relationship between insomnia and body temperatures.Sleep Med. Rev.12307–317. 10.1016/j.smrv.2008.02.003
99
LacourseK.YettonB.MednickS.WarbyS. C. (2020). Massive online data annotation, crowdsourcing to generate high quality sleep spindle annotations from EEG data.Sci. Data71–14. 10.1038/s41597-020-0533-4
100
LafortuneM.GagnonJ. F.MartinN.LatreilleV.DubéJ.BouchardM.et al (2014). Sleep spindles and rapid eye movement sleep as predictors of next morning cognitive performance in healthy middle-aged and older participants.J. Sleep Res.23159–167. 10.1111/jsr.12108
101
LandryS. A.JoostenS. A.EckertD. J.JordanA. S.SandsS. A.WhiteD. P.et al (2017). Therapeutic CPAP level predicts upper airway collapsibility in patients with obstructive sleep apnea.Sleep40:zsx056. 10.1093/sleep/zsx056
102
LaurinoM.ArcarisiL.CarbonaroN.GemignaniA.MenicucciD.TognettiA. (2020). A smart bed for non-obtrusive sleep analysis in real world context.IEEE Access845664–45673. 10.1109/ACCESS.2020.2976194
103
LawR.ClowA. (2020). Stress, the cortisol awakening response and cognitive function.Int. Rev. Neurobiol.150187–217. 10.1016/bs.irn.2020.01.001
104
LazarA. S.LazarZ. I.DijkD.-J. (2015). Circadian regulation of slow waves in human sleep: topographical aspects.Neuroimage116123–134. 10.1016/j.neuroimage.2015.05.012
105
LechatB.HansenK.CatchesideP.ZajamsekB. (2020). Beyond K-complex binary scoring during sleep: probabilistic classification using deep learning.Sleep43:zsaa077. 10.1093/sleep/zsaa077
106
LechatB.HansenK.MicicG.DecupF.DunbarC.LiebichT.et al (2021). K-complexes are a sensitive marker of noise-related sensory processing during sleep: a pilot study.Sleep44:zsab065. 10.1093/sleep/zsab065
107
LégerD.DebellemaniereE.RabatA.BayonV.BenchenaneK.ChennaouiM. (2018). Slow-wave sleep: from the cell to the clinic.Sleep Med. Rev.41113–132. 10.1016/j.smrv.2018.01.008
108
LendnerJ. D.HelfrichR. F.ManderB. A.RomundstadL.LinJ. J.WalkerM. P.et al (2020). An electrophysiological marker of arousal level in humans.Elife9:e55092. 10.7554/eLife.55092.sa2
109
LevyP.PépinJ. L.Deschaux-BlancC.ParamelleB.BrambillaC. (1996). Accuracy of oximetry for detection of respiratory disturbances in sleep apnea syndrome.Chest109395–399. 10.1378/chest.109.2.395
110
LiS.WingY.LamS.ZhangJ.YuM.HoC.et al (2010). Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK).Sleep Med.1143–48. 10.1016/j.sleep.2009.06.008
111
LiY.YeJ.HanD.CaoX.DingX.ZhangY.et al (2017). Physiology-Based modeling may predict surgical treatment outcome for obstructive sleep apnea.J. Clin. Sleep Med.131029–1037. 10.5664/jcsm.6716
112
LimD. C.MazzottiD. R.SutherlandK.MindelJ. W.KimJ.CistulliP. A.et al (2020). Reinventing polysomnography in the age of precision medicine.Sleep Med. Rev.52:101313. 10.1016/j.smrv.2020.101313
113
LinC.-L.YehC.YenC.-W.HsuW.-H.HangL.-W. (2009). Comparison of the indices of oxyhemoglobin saturation by pulse oximetry in obstructive sleep apnea hypopnea syndrome.Chest13586–93. 10.1378/chest.08-0057
114
LindnerA.FornadiK.LazarA. S.CziraM. E.DunaiA.ZollerR.et al (2012). Periodic limb movements in sleep are associated with stroke and cardiovascular risk factors in patients with renal failure.J. Sleep Res.21297–307. 10.1111/j.1365-2869.2011.00956.x
115
LinzD.BaumertM.DestegheL.KadhimK.VernooyK.KalmanJ. M.et al (2019a). Nightly sleep apnea severity in patients with atrial fibrillation: potential applications of long-term sleep apnea monitoring.IJC Heart Vasculature24:100424. 10.1016/j.ijcha.2019.100424
116
LinzD.BrooksA. G.ElliottA. D.NalliahC. J.HendriksJ. M.MiddeldorpM. E.et al (2019b). Variability of sleep apnea severity and risk of atrial fibrillation: the VARIOSA-AF study.JACC: Clin. Electrophys.5692–701. 10.1016/j.jacep.2019.03.005
117
LinzD.LofflerK. A.SandersP.CatchesideP.AndersonC. S.ZhengD.et al (2020). Low prognostic value of novel nocturnal metrics in patients with OSA and high cardiovascular event risk: post hoc analyses of the SAVE Study.Chest1582621–2631. 10.1016/j.chest.2020.06.072
118
LiuS.PanJ.LeiQ.HeL.ZhongB.MengY.et al (2020). Spontaneous K-Complexes may be biomarkers of the progression of amnestic mild cognitive impairment.Sleep Med.6799–109. 10.1016/j.sleep.2019.10.015
119
LiuY.PharrM.SalvatoreG. A. (2017). Lab-on-skin: a review of flexible and stretchable electronics for wearable health monitoring.ACS Nano119614–9635. 10.1021/acsnano.7b04898
120
Lunsford-AveryJ. R.EdingerJ. D.KrystalA. D. (2021). Optimizing computation of overnight decline in delta power: evidence for slower rate of decline in delta power in insomnia patients.Clin. Neurophysiol.132545–553. 10.1016/j.clinph.2020.12.004
121
MaC.PavlovaM.LiuY.LiuY.HuangfuC.WuS.et al (2017). Probable REM sleep behavior disorder and risk of stroke: a prospective study.Neurology881849–1855. 10.1212/WNL.0000000000003902
122
MagalangU. J.ChenN.-H.CistulliP. A.FedsonA. C.GíslasonT.HillmanD.et al (2013). Agreement in the scoring of respiratory events and sleep among international sleep centers.Sleep36591–596. 10.5665/sleep.2552
123
MagalangU. J.DmochowskiJ.VeeramachaneniS.DrawA.MadorM. J.El-SolhA.et al (2003). Prediction of the apnea-hypopnea index from overnight pulse oximetry.Chest1241694–1701. 10.1378/chest.124.5.1694
124
MalhotraA.MesarwiO.PepinJ.-L.OwensR. L. (2020). Endotypes and phenotypes in obstructive sleep apnea.Curr. Opin. Pulmonary Med.26:609. 10.1097/MCP.0000000000000724
125
MarchiN. A.RamponiC.HirotsuC.Haba-RubioJ.LuttiA.PreisigM.et al (2020). Mean oxygen saturation during sleep is related to specific brain atrophy pattern.Ann. Neurol.87921–930. 10.1002/ana.25728
126
MassiminiM.HuberR.FerrarelliF.HillS.TononiG. (2004). The sleep slow oscillation as a traveling wave.J. Neurosci.246862–6870. 10.1523/JNEUROSCI.1318-04.2004
127
MendonçaF.MostafaS. S.Morgado-DiasF.Ravelo-GarciaA. G.PenzelT. (2019). A review of approaches for sleep quality analysis.IEEE Access724527–24546. 10.1109/ACCESS.2019.2900345
128
MicicG.LovatoN.GradisarM.FergusonS. A.BurgessH. J.LackL. C. (2016). The etiology of delayed sleep phase disorder.Sleep Med. Rev.2729–38. 10.1016/j.smrv.2015.06.004
129
MosqueiroT.de LeceaL.HuertaR. (2014). Control of sleep-to-wake transitions via fast amino acid and slow neuropeptide transmission.New J. Phys.16:115010. 10.1088/1367-2630/16/11/115010
130
MuehlrothB. E.SanderM. C.FandakovaY.GrandyT. H.RaschB.ShingY. L.et al (2019). Precise slow oscillation–spindle coupling promotes memory consolidation in younger and older adults.Sci. Rep.91–15. 10.1038/s41598-018-36557-z
131
MullinsA. E.KimJ. W.WongK. K.BartlettD. J.VakulinA.DijkD.-J.et al (2021). Sleep EEG microstructure is associated with neurobehavioural impairment after extended wakefulness in obstructive sleep apnea.Sleep Breathing25347–354. 10.1007/s11325-020-02066-5
132
MuzetA. (2007). Environmental noise, sleep and health.Sleep Med. Rev.11135–142. 10.1016/j.smrv.2006.09.001
133
NetzerN.EliassonA. H.NetzerC.KristoD. A. (2001). Overnight pulse oximetry for sleep-disordered breathing in adults: a review.Chest120625–633. 10.1378/chest.120.2.625
134
NirY.StabaR. J.AndrillonT.VyazovskiyV. V.CirelliC.FriedI.et al (2011). Regional slow waves and spindles in human sleep.Neuron70153–169. 10.1016/j.neuron.2011.02.043
135
NortonJ. J.LeeD. S.LeeJ. W.LeeW.KwonO.WonP.et al (2015). Soft, curved electrode systems capable of integration on the auricle as a persistent brain–computer interface.Proc. Natl. Acad. Sci. U.S.A.1123920–3925. 10.1073/pnas.1424875112
136
OlesenA. N.Jørgen JennumP.MignotE.SorensenH. B. D. (2021). Automatic sleep stage classification with deep residual networks in a mixed-cohort setting.Sleep44:zsaa161. 10.1093/sleep/zsaa161
137
OlivaD.HongistoV.HaapakangasA. (2017). Annoyance of low-level tonal sounds–Factors affecting the penalty.Build. Environ.123404–414. 10.1016/j.buildenv.2017.07.017
138
O’NeillJ. S.ReddyA. B. (2011). Circadian clocks in human red blood cells.Nature469498–503. 10.1038/nature09702
139
Op de BeeckS.WellmanA.DieltjensM.StrohlK. P.WillemenM.Van de HeyningP. H.et al (2021). Endotypic mechanisms of successful hypoglossal nerve stimulation for obstructive sleep apnea.Am. J. Respir. Crit. Care Med.203746–755. 10.1164/rccm.202006-2176OC
140
OsmanA. M.CarberryJ. C.BurkeP. G.TosonB.GrunsteinR. R.EckertD. J. (2019). Upper airway collapsibility measured using a simple wakefulness test closely relates to the pharyngeal critical closing pressure during sleep in obstructive sleep apnea.Sleep42:zsz080. 10.1093/sleep/zsz080
141
OsmanA. M.TongB. K.LandryS. A.EdwardsB. A.JoostenS. A.HamiltonG. S.et al (2020). An assessment of a simple clinical technique to estimate pharyngeal collapsibility in people with obstructive sleep apnea.Sleep43:zsaa067. 10.1093/sleep/zsaa067
142
PaganoG.De MiccoR.YousafT.WilsonH.ChandraA.PolitisM. (2018). REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.Neurology91e894–e905. 10.1212/WNL.0000000000006134
143
ParekhA.KamK.MullinsA. E.CastilloB.BerkalievaA.MazumdarM.et al (2021). Altered K-complex morphology during sustained inspiratory airflow limitation is associated with next-day lapses in vigilance in obstructive sleep apnea.Sleep44:zsab010. 10.1093/sleep/zsab010
144
ParekhA.MullinsA. E.KamK.VargaA. W.RapoportD. M.AyappaI. (2019). Slow-wave activity surrounding stage N2 K-complexes and daytime function measured by psychomotor vigilance test in obstructive sleep apnea.Sleep42:zsy256. 10.1093/sleep/zsy256
145
ParekhA.SelesnickI. W.RapoportD. M.AyappaI. (2015). Detection of K-complexes and sleep spindles (DETOKS) using sparse optimization.J. Neurosci. Methods25137–46. 10.1016/j.jneumeth.2015.04.006
146
ParlakO.KeeneS. T.MaraisA.CurtoV. F.SalleoA. (2018). Molecularly selective nanoporous membrane-based wearable organic electrochemical device for noninvasive cortisol sensing.Sci. Adv.4:eaar2904. 10.1126/sciadv.aar2904
147
PengoM. F.RatneswaranC.BerryM.KentB. D.KohlerM.RossiG. P.et al (2016). Effect of continuous positive airway pressure on blood pressure variability in patients with obstructive sleep apnea.J. Clin. Hypertens.181180–1184. 10.1111/jch.12845
148
PenzelT.KantelhardtJ. W.BartschR. P.RiedlM.KraemerJ. F.WesselN.et al (2016). Modulations of heart rate, ECG, and cardio-respiratory coupling observed in polysomnography.Front. Physiol.7:460. 10.3389/fphys.2016.00460
149
PlanteD. T. (2014). Leg actigraphy to quantify periodic limb movements of sleep: a systematic review and meta-analysis.Sleep Med. Rev.18425–434. 10.1016/j.smrv.2014.02.004
150
PrerauM. J.BrownR. E.BianchiM. T.EllenbogenJ. M.PurdonP. L. (2017). Sleep neurophysiological dynamics through the lens of multitaper spectral analysis.Physiology3260–92. 10.1152/physiol.00062.2015
151
PrerauM. J.HartnackK. E.Obregon-HenaoG.SampsonA.MerlinoM.GannonK.et al (2014). Tracking the sleep onset process: an empirical model of behavioral and physiological dynamics.PLoS Computational Biol.10:e1003866. 10.1371/journal.pcbi.1003866
152
PrettoJ. J.RoebuckT.BeckertL.HamiltonG. (2014). Clinical use of pulse oximetry: official guidelines from the T horacic S ociety of A ustralia and N ew Z ealand.Respirology1938–46. 10.1111/resp.12204
153
PunjabiN. M.NewmanA. B.YoungT. B.ResnickH. E.SandersM. H. (2008). Sleep-disordered breathing and cardiovascular disease: an outcome-based definition of hypopneas.Am. J. Respiratory Crit. Care Med.1771150–1155. 10.1164/rccm.200712-1884OC
154
PunjabiN. M.PatilS.CrainiceanuC.AuroraR. N. (2020). Variability and misclassification of sleep apnea severity based on multi-night testing.Chest158365–373. 10.1016/j.chest.2020.01.039
155
PurcellS.ManoachD.DemanueleC.CadeB.MarianiS.CoxR.et al (2017). Characterizing sleep spindles in 11,630 individuals from the National Sleep Research Resource.Nat. Commun.81–16. 10.1038/ncomms15930
156
PuriS.El-ChamiM.ShaheenD.IversB.PanzaG. S.BadrM. S.et al (2020). Variations in loop gain and arousal threshold during NREM sleep are affected by time of day over a 24-hour period in participants with obstructive sleep apnea.J. Appl. Physiol.129800–809. 10.1152/japplphysiol.00376.2020
157
QinH.KeenanB. T.MazzottiD. R.Vaquerizo-VillarF.KraemerJ. F.WesselN.et al (2021). Heart rate variability during wakefulness as a marker of obstructive sleep apnea severity.Sleep44:zsab018. 10.1093/sleep/zsab018
158
RechtschaffenA.KalesA. (1968). A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages of Human Subjects. Washington, DC: Washington Public Health Service, US Government Printing Office.
159
RedlineS.PurcellS. M. (2021). Sleep and Big Data: Harnessing Data, Technology, and Analytics for Monitoring Sleep and Improving Diagnostics, Prediction, and Interventions—an Era for Sleep-Omics?.Oxford: Oxford University Press US. 10.1093/sleep/zsab107
160
ReidK. J. (2019). Assessment of circadian rhythms.Neurol. Clin.37505–526. 10.1016/j.ncl.2019.05.001
161
RothT.CoulouvratC.HajakG.LakomaM. D.SampsonN. A.ShahlyV.et al (2011). Prevalence and perceived health associated with insomnia based on DSM-IV-TR; international statistical classification of diseases and related health problems, tenth revision; and research diagnostic criteria/international classification of sleep disorders, criteria: results from the America insomnia survey.Biol. Psychiatry69592–600. 10.1016/j.biopsych.2010.10.023
162
RuehlandW. R.RochfordP. D.O’DonoghueF. J.PierceR. J.SinghP.ThorntonA. T. (2009). The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index.Sleep32150–157. 10.1093/sleep/32.2.150
163
SandsS. A.EdwardsB. A.TerrillP. I.ButlerJ. P.OwensR. L.Taranto-MontemurroL.et al (2018a). Identifying obstructive sleep apnoea patients responsive to supplemental oxygen therapy.Eur. Respiratory J.52:1800674. 10.1183/13993003.00674-2018
164
SandsS. A.TerrillP. I.EdwardsB. A.Taranto MontemurroL.AzarbarzinA.MarquesM.et al (2018b). Quantifying the arousal threshold using polysomnography in obstructive sleep apnea.Sleep41:zsx183. 10.1093/sleep/zsx183
165
SaperC. B.FullerP. M. (2017). Wake–sleep circuitry: an overview.Curr. Opin. Neurobiol.44186–192. 10.1016/j.conb.2017.03.021
166
ScammellT. E.ArrigoniE.LiptonJ. O. (2017). Neural circuitry of wakefulness and sleep.Neuron93747–765. 10.1016/j.neuron.2017.01.014
167
SchäfferB.SchlittmeierS. J.PierenR.HeutschiK.BrinkM.GrafR.et al (2016). Short-term annoyance reactions to stationary and time-varying wind turbine and road traffic noise: a laboratory study.J. Acoustical Soc. Am.1392949–2963. 10.1121/1.4949566
168
ScottH.LechatB.LovatoN.LackL. (2020). Correspondence between physiological and behavioural responses to vibratory stimuli during the sleep onset period: a quantitative electroencephalography analysis.J. Sleep Res.30:e13232. 10.1111/jsr.13232
169
ScottH.LovatoN.LackL. (2021). The development and accuracy of the THIM wearable device for estimating sleep and wakefulness.Nat. Sci. Sleep13:39. 10.2147/NSS.S287048
170
SforzaE.PichotV.Saint MartinM.BarthélémyJ. C.RocheF. (2015). Prevalence and determinants of subjective sleepiness in healthy elderly with unrecognized obstructive sleep apnea.Sleep Med.16981–986. 10.1016/j.sleep.2015.03.010
171
Shokri-KojoriE.WangG.-J.WiersC. E.DemiralS. B.GuoM.KimS. W.et al (2018). β-Amyloid accumulation in the human brain after one night of sleep deprivation.Proc. Natl. Acad. Sci. U.S.A.1154483–4488. 10.1073/pnas.1721694115
172
SlettenT. L.MageeM.MurrayJ. M.GordonC. J.LovatoN.KennawayD. J.et al (2018). Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: a double-blind, randomised clinical trial.PLoS Med.15:e1002587. 10.1371/journal.pmed.1002587
173
StephensonR. (2003). Do circadian rhythms in respiratory control contribute to sleep-related breathing disorders?Sleep Med. Rev.7475–490. 10.1016/S1087-0792(03)90002-5
174
SteriadeM. (2006). Grouping of brain rhythms in corticothalamic systems.Neuroscience1371087–1106. 10.1016/j.neuroscience.2005.10.029
175
StevensD.LeongC. W. Y.CheungH.ArciuliJ.VakulinA.KimJ. W.et al (2021). Sleep spindle activity correlates with implicit statistical learning consolidation in untreated obstructive sleep apnea patients.Sleep Med. [Online ahead of print]10.1016/j.sleep.2021.01.035
176
Stiasny-KolsterK.MayerG.SchäferS.MollerJ. C.Heinzel-GutenbrunnerM.OertelW. H. (2007). The REM sleep behavior disorder screening questionnaire—a new diagnostic instrument.Mov. Disord.222386–2393. 10.1002/mds.21740
177
StoneJ. E.McGlashanE. M.QuinN.SkinnerK.StephensonJ. J.CainS. W.et al (2020). The role of light sensitivity and intrinsic circadian period in predicting individual circadian timing.J. Biol. Rhythms35628–640. 10.1177/0748730420962598
178
SuW.ChenG.MaD.ZengJ.YanF.LinX.et al (2021). Higher Apnea-Hypopnea Index (AHI) and Oxygen Desaturation Index (ODI) were independently associated with increased risks of hypertension in patients with T2DM: a cross-sectional study.Int. J. Hypertens.2021:8887944. 10.1155/2021/8887944
179
SuárezA.NúñezF.Rodriguez-FernandezM. (2020). Circadian phase prediction from non-intrusive and ambulatory physiological data.IEEE J. Biomed. Health Inform.251561–1571. 10.1109/JBHI.2020.3019789
180
SullivanC.Berthon-JonesM.IssaF.EvesL. (1981). Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares.Lancet317862–865. 10.1016/S0140-6736(81)92140-1
181
SupratakA.DongH.WuC.GuoY. (2017). DeepSleepNet: a model for automatic sleep stage scoring based on raw single-channel EEG.IEEE Trans. Neural Syst. Rehabil. Eng.251998–2008. 10.1109/TNSRE.2017.2721116
182
SweetmanA.ReynoldsA.LackL. C. (2021). Circadian factors in comorbid insomnia and sleep apnea (COMISA).J. Clin. Sleep Med. [Online ahead of print] jcsm.9408. 10.5664/jcsm.9408
183
Taranto-MontemurroL.MessineoL.SandsS. A.AzarbarzinA.MarquesM.EdwardsB. A.et al (2019). The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial.Am. J. Respiratory Crit. Care Med.1991267–1276. 10.1164/rccm.201808-1493OC
184
TerrillP. I. (2020). A review of approaches for analysing obstructive sleep apnoea-related patterns in pulse oximetry data.Respirology25475–485. 10.1111/resp.13635
185
TerzanoM. G.ParrinoL.SherieriA.ChervinR.ChokrovertyS.GuilleminaultC.et al (2001). Atlas, rules, and recording techniques for the scoring of cyclic alternating pattern (CAP) in human sleep.Sleep Med.2537–553. 10.1016/S1389-9457(01)00149-6
186
ThomasR. J.MietusJ. E.PengC.-K.GoldbergerA. L. (2005). An electrocardiogram-based technique to assess cardiopulmonary coupling during sleep.Sleep281151–1161. 10.1093/sleep/28.9.1151
187
ThomasR. J.WoodC.BianchiM. T. (2018). Cardiopulmonary coupling spectrogram as an ambulatory clinical biomarker of sleep stability and quality in health, sleep apnea, and insomnia.Sleep41:zsx196. 10.1093/sleep/zsx196
188
TononiG.CirelliC. (2006). Sleep function and synaptic homeostasis.Sleep Med. Rev.1049–62. 10.1016/j.smrv.2005.05.002
189
TrauerJ. M.QianM. Y.DoyleJ. S.RajaratnamS. M.CunningtonD. (2015). Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis.Ann. Internal Med.163191–204. 10.7326/M14-2841
190
TsinalisO.MatthewsP. M.GuoY.ZafeiriouS. (2016). Automatic sleep stage scoring with single-channel EEG using convolutional neural networks.arXiv preprint arXiv1610.01683. (accessed June, 2019).
191
TuominenJ.PeltolaK.SaaresrantaT.ValliK. (2019). Sleep parameter assessment accuracy of a consumer home sleep monitoring ballistocardiograph beddit sleep tracker: a validation study.J. Clin. Sleep Med.15483–487. 10.5664/jcsm.7682
192
UcakS.DissanayakeH. U.SutherlandK.de ChazalP.CistulliP. A. (2021). Heart rate variability and obstructive sleep apnea: current perspectives and novel technologies.J. Sleep Res.30:e13274. 10.1111/jsr.13274
193
UpashamS.PrasadS. (2020). SLOCK (sensor for circadian clock): passive sweat-based chronobiology tracker.Lab Chip201947–1960. 10.1039/D0LC00134A
194
VakulinA.D’RozarioA.KimJ.-W.WatsonB.CrossN.WangD.et al (2016). Quantitative sleep EEG and polysomnographic predictors of driving simulator performance in obstructive sleep apnea.Clin. Neurophysiol.1271428–1435. 10.1016/j.clinph.2015.09.004
195
von AllmenD. C.FranceyL. J.RogersG. M.RubenM. D.CohenA. P.WuG.et al (2018). Circadian dysregulation: the next frontier in obstructive sleep apnea research.Otolaryngol.–Head Neck Surg.159948–955. 10.1177/0194599818797311
196
WangD.WongK. K.RowsellL.DonG. W.YeeB. J.GrunsteinR. R. (2018). Predicting response to oxygen therapy in obstructive sleep apnoea patients using a 10-minute daytime test.Eur. Respiratory J.51:1701587. 10.1183/13993003.01587-2017
197
WangY.-K.ChenH.-Y.ChenJ.-R.LinC.-M.ChiuH.-C. (2013). “A novel sleep/wake identification method with video analysis,” in Proceeding of the 2013 International Conference on Machine Learning and Cybernetics: IEEE, (IEEE), 1130–1135. 10.1109/ICMLC.2013.6890761
198
WarbyS. C.WendtS. L.WelinderP.MunkE. G.CarrilloO.SorensenH. B.et al (2014). Sleep-spindle detection: crowdsourcing and evaluating performance of experts, non-experts and automated methods.Nat. Methods11385–392. 10.1038/nmeth.2855
199
WaserM.StefaniA.HolzknechtE.KohnB.HacknerH.BrandauerE.et al (2020). Automated 3D video analysis of lower limb movements during REM sleep: a new diagnostic tool for isolated REM sleep behavior disorder.Sleep43:zsaa100. 10.1093/sleep/zsaa100
200
YamauchiM.JaconoF. J.FujitaY.KumamotoM.YoshikawaM.CampanaroC. K.et al (2014). Effects of environment light during sleep on autonomic functions of heart rate and breathing.Sleep Breathing18829–835. 10.1007/s11325-014-0951-7
201
YounesM.AzarbarzinA.ReidM.MazzottiD. R.RedlineS. (2021). Characteristics and reproducibility of novel sleep EEG biomarkers and their variation with sleep apnea and insomnia in a large community-based cohort.Sleep [Online ahead of print]10.1093/sleep/zsab145
202
YounesM.GiannouliE. (2020). Mechanism of excessive wake time when associated with obstructive sleep apnea or periodic limb movements.J. Clin. Sleep Med.16389–399. 10.5664/jcsm.8214
203
YounesM.HanlyP. J. (2016). Immediate postarousal sleep dynamics: an important determinant of sleep stability in obstructive sleep apnea.J. Appl. Physiol.120801–808. 10.1152/japplphysiol.00880.2015
204
YounesM.OstrowskiM.SoifermanM.YounesH.YounesM.RaneriJ.et al (2015). Odds ratio product of sleep EEG as a continuous measure of sleep state.Sleep38641–654. 10.5665/sleep.4588
205
YounesM.SchweitzerP. K.GriffinK. S.BalshawR.WalshJ. K. (2020). Comparing two measures of sleep depth/intensity.Sleep43:zsaa127. 10.1093/sleep/zsaa127
206
ZakrzewskiM.VehkaojaA.JoutsenA. S.PalovuoriK. T.VanhalaJ. J. (2015). Noncontact respiration monitoring during sleep with microwave Doppler radar.IEEE Sensors J.155683–5693. 10.1109/JSEN.2015.2446616
207
ZhaoW.Van SomerenE. J.LiC.ChenX.GuiW.TianY.et al (2021). EEG spectral analysis in insomnia disorder: a systematic review and meta-analysis.Sleep Med. Rev.59:101457. 10.1016/j.smrv.2021.101457
208
ZinchukA. V.ChuJ. H.LiangJ.CelikY.Op de BeeckS.RedekerN. S.et al (2021). Physiological traits and adherence to therapy of sleep apnea in individuals with coronary artery disease.Am. J. Respir. Crit. Care Med. [Online ahead of print]10.1164/rccm.202101-0055OC
Summary
Keywords
sleep disordered breathing, sleep apnea, insomnia, circadian rhythm, polysomnography, signal processing, apnea/hypopnea index, precision medicine
Citation
Lechat B, Scott H, Naik G, Hansen K, Nguyen DP, Vakulin A, Catcheside P and Eckert DJ (2021) New and Emerging Approaches to Better Define Sleep Disruption and Its Consequences. Front. Neurosci. 15:751730. doi: 10.3389/fnins.2021.751730
Received
01 August 2021
Accepted
16 September 2021
Published
07 October 2021
Volume
15 - 2021
Edited by
David Gozal, University of Missouri, United States
Reviewed by
Robert J. Thomas, Beth Israel Deaconess Medical Center and Harvard Medical School, United States; Saif Mashaqi, The University of Arizona, United States
Updates
Copyright
© 2021 Lechat, Scott, Naik, Hansen, Nguyen, Vakulin, Catcheside and Eckert.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Danny J. Eckert, danny.eckert@flinders.edu.au
†These authors have contributed equally to this work
This article was submitted to Sleep and Circadian Rhythms, a section of the journal Frontiers in Neuroscience
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.